Follow-Up Care Is Recommended for Children Prescribed ADHD Medication
AI Summary
Blue Cross Blue Star of Texas is tracking a new HEDIS quality measure for ADHD medication follow-up care in children ages 6-12. Providers must ensure children prescribed ADHD medication have one follow-up visit within 30 days of first prescription and at least two follow-up visits within 9 months of the initiation phase.
Action Required
Immediately: Pediatric providers and billing teams should implement tracking systems to ensure ADHD medication follow-up visits are scheduled and documented according to HEDIS requirements. Schedule one follow-up visit within 30 days of initial ADHD prescription and at least two follow-up visits within 270 days of initiation phase. Document visits with prescribing authority providers and ensure children remain on medication for at least 210 days. This affects quality measure reporting and potential reimbursement incentives.
Plan Types
Commercial
States
TX
Specialties
pediatrics, psychiatry, family-medicine